Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus oxytocin for prevention and management of postpartum hemorrhage after vaginal delivery
IRCT20250315065085N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, triple-blind trial of tranexamic acid and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Change in hemoglobin, Change in hematocrit and 12 more. Started May 2025; status: completed.
02
Drugs
tranexamic acidoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20250315065085N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250315065085N1.